CLINICAL_TRIALS
trial_result
· 2017-05-17
Clinical Trial Update: Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia [NA]
Summary
A clinical trial evaluating flecainide for catecholaminergic polymorphic ventricular tachycardia has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanderbilt University Medical Center | Conditions: Catecholaminergic Polymorphic Ventricular Tachycardia | NA | Status: COMPLETED | Results posted: 2017-05-17